Publication:
Modeling hepatocellular carcinoma cells dynamics by serological and imaging biomarkers in patients with response to sorafenib and/or regorafenib

dc.contributor.authorsColombatto, P.; Demirtas, C. O.; Ricco, G.; Civitano, L.; Boraschi, P.; Scalise, P.; Cavallone, D.; Oliveri, F.; Romagnoli, V.; Bleve, P.; Coco, B.; Salvati, A.; Urbani, L.; Bonino, F.; Brunetto, M. R.
dc.date.accessioned2022-03-10T18:02:45Z
dc.date.accessioned2026-01-10T18:32:21Z
dc.date.available2022-03-10T18:02:45Z
dc.date.issued2021
dc.identifier.doidoiWOS:000622801600081
dc.identifier.eissn1878-3562
dc.identifier.issn1590-8658
dc.identifier.urihttps://hdl.handle.net/11424/222428
dc.identifier.wosWOS:000622801600081
dc.language.isoeng
dc.publisherELSEVIER SCIENCE INC
dc.relation.ispartofDIGESTIVE AND LIVER DISEASE
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.titleModeling hepatocellular carcinoma cells dynamics by serological and imaging biomarkers in patients with response to sorafenib and/or regorafenib
dc.typeconferenceObject
dc.type.submeetingabstract
dspace.entity.typePublication
oaire.citation.endPageS40
oaire.citation.startPageS39
oaire.citation.titleDIGESTIVE AND LIVER DISEASE
oaire.citation.volume53

Files